May 11, 2020 / 5:33 AM / in 3 months

Roche's U.S. gRED research head to retire, be replaced by MIT's Regev

ZURICH, May 11 (Reuters) - Swiss drugmaker Roche said on Monday that the head of its U.S. research arm gRED, Michael Varney, is retiring and will be replaced by Aviv Regev, now a biology professor at the Massachusetts Institute of Technology (MIT).

The Israeli-American, born in 1971, is chair of the faculty, core institute member, and member of the executive leadership team of the Broad Institute of MIT and Harvard University. Regev is also a biology professor at MIT and investigator of the Howard Hughes Medical Institute, Roche said. (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below